FIELD: chemistry.
SUBSTANCE: invention pertains to tricyclic derivatives, represented by formula (I) or to their pharmaceutical salts, which have proliferative activity and ability to inhibit angiogenesis, to the method of obtaining them (alternatives), the proliferative agent and an angiogenesis inhibitor on their base. , where R1 represents T1B1; Ti represents -N(R5)C(O)-, where R5 represents H or C1-C5 alkyl group; and B1 is chosen from a group, consisting of the following values (a),(b),(f),(g): , where represents , or ; R6 represents H, halogen or hydroxy group; R7 represents a hydroxy or -ONO2 group, under the condition that R6 represents H, R7 is different from hydroxyl; T2 represents -O-C(O)-; B2 the stated (a) group or -Z1-R7, where Z1 represents a linear C2-C5alkyl group, n2 represents an integer 0-3; and n3 represents an integer 0-5; R2 represents CH3; R3 represents C1-C4 unbranched or branched alkyl, or C3-C7 cycloalkyl, under the condition that, if B1 represents (a), R6 represents H, R7 represents an -ONO2 group and R3 is not CH3; R4 represents SCH3 or OCH3; X represents O.
EFFECT: perfection of the method of obtaining compounds.
7 cl, 6 tbl, 14 dwg, 48 ex
Title | Year | Author | Number |
---|---|---|---|
(S)-4-OXO-N-(1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDROBENZO[a]HEPTALEN-7-yl)PENTANAMIDE DERIVATIVE AND ITS USE | 2022 |
|
RU2809516C1 |
NOVEL TRICYCLIC DERIVATIVE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, METHOD FOR PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITION CONTAINING SAID DERIVATIVE | 2009 |
|
RU2470934C1 |
NOVEL CRYSTALLINE ACID-ADDITION SALTS OF TRICYCLIC DERIVATIVE OR THEIR HYDRATES AND METHOD FOR THEREOF OBTAINING | 2013 |
|
RU2572820C1 |
NOVEL BENZAMIDE DERIVATIVES | 2011 |
|
RU2536688C2 |
GLUCOKINASE ACTIVATORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AS ACTIVE INGREDIENT | 2008 |
|
RU2450001C2 |
INDANONE DERIVATIVE, ITS PHARMACEUTICALLY ACCEPTABLE SALT OR ENANTIOMER, METHOD FOR PRODUCING IT AND PHARMACEUTICAL COMPOSITION CONTAINING IT AND APPLICABLE FOR PREVENTING OR TREATING VIRAL DISEASE | 2012 |
|
RU2574591C2 |
COMPOUND CONTAINING OXADIAZOLE AND A PHARMACEUTICAL COMPOSITION CONTAINING IT | 2019 |
|
RU2789456C2 |
NOVEL COMPOUNDS, ISOMERS THEREOF OR PHARMACUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONISTS AND PHARMACEUTICAL COMPOSITION CONTAINING SAID COMPOUNDS | 2007 |
|
RU2448108C2 |
MACROCYCLIZATION REACTIONS AND INTERMEDIATE COMPOUNDS AND OTHER FRAGMENTS SUITABLE FOR PREPARING ANALOGUES OF HALICHONDRIN B | 2014 |
|
RU2710545C2 |
NEW PYRIDINE DERIVATIVES, METHOD FOR MAKING THEREOF AND RELATED PHARMACEUTICAL COMPOSITION | 2004 |
|
RU2366659C2 |
Authors
Dates
2008-06-20—Published
2004-06-23—Filed